Recruiting Ankylosing Spondylitis Studies in Hines
Pimavanserin vs. Quetiapine for Treatment of Parkinson's Psychosis
Patients with Parkinson's disease (PD) sometimes experience symptoms affecting their movement, such as slowness, tremor, stiffness, and balance or walking problems. Many patients also have other sympt...
rTMS to Improve Cognition in Parkinson's
The purpose of this study is to examine safety, feasibility, and the behavioral and brain effects of a non-invasive treatment, repetitive transcranial magnetic stimulation (rTMS), for Veterans with Pa...
About Ankylosing Spondylitis Clinical Trials in Hines
Ankylosing spondylitis is a chronic inflammatory disease primarily affecting the spine and sacroiliac joints, causing pain, stiffness, and potentially spinal fusion. It typically begins in early adulthood. Treatment includes NSAIDs, biologics (TNF and IL-17 inhibitors), and physical therapy.
There are currently 2 ankylosing spondylitis clinical trials recruiting participants in Hines, IL. These studies are seeking a combined 414 participants. Research is being sponsored by VA Office of Research and Development. Clinical trial participation is free and participants receive study-related medical care at no cost.
Ankylosing Spondylitis Clinical Trials in Hines — FAQ
Are there ankylosing spondylitis clinical trials in Hines?
Yes, there are 2 ankylosing spondylitis clinical trials currently recruiting in Hines, IL. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Hines?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Hines research site will contact you about next steps.
Are clinical trials in Hines free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Hines studies also compensate for your time and travel.
What ankylosing spondylitis treatments are being tested?
The 2 active trials in Hines are testing new therapies including novel drugs, biologics, and treatment approaches for ankylosing spondylitis.
Data updated March 2, 2026 from ClinicalTrials.gov